Literature DB >> 27196582

Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based first-line treatment failed.

Yasumi Katayama1, Kouji Toyoda1, Yuumi Kusano1, Toshikuni Suda1, Shogo Adachi1,2, Itsuo Terauchi3, Shigeki Oka4, Morio Takahashi5, Masaya Tamano1.   

Abstract

Entities:  

Keywords:  ANTIBIOTIC THERAPY; HELICOBACTER PYLORI - TREATMENT; PROTON PUMP INHIBITION

Mesh：

Substances：

Year:  2016        PMID： 27196582     DOI： 10.1136/gutjnl-2016-312028

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

Review 1.  Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.

Authors:  Hiroki Tanabe; Katsuyoshi Ando; Kiichi Sato; Takahiro Ito; Mitsuru Goto; Tomonobu Sato; Akihiro Fujinaga; Toru Kawamoto; Tatsuya Utsumi; Nobuyuki Yanagawa; Eiichiro Ichiishi; Takaaki Otake; Yutaka Kohgo; Yoshiki Nomura; Nobuhiro Ueno; Hiroko Sugano; Shin Kashima; Kentaro Moriichi; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Dig Dis Sci       Date:  2017-06-29       Impact factor: 3.199

2.  Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori.

Authors:  Naoyoshi Mori; Yuuki Nishiura; Daisuke Suga; Isao Moritani; Yutaka Yamanaka; Yumi Ooya; Hidekazu Inoue; Koujirou Takase; Masato Hioki; Katsuya Shiraki
Journal:  Biomed Rep       Date:  2018-06-11

3.  Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients.

Authors:  Daisuke Fukuda; Yuko Akazawa; Fuminao Takeshima; Kazuhiko Nakao; Yutaka Fukuda
Journal:  Therap Adv Gastroenterol       Date:  2016-06-20       Impact factor: 4.409

Review 4.  Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

Review 5.  Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Front Pharmacol       Date:  2019-01-15       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.